TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
COLL

Collegium Pharmaceutical Inc

Healthcare · Drug Manufacturers - Specialty & Generic

22.60$ +0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Collegium Pharmaceutical Inc (COLL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,136 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COLL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
99 162 140 125 123 136 696 673 647 291 294 302 304 306 635 647 644 644 646 714 742 692 1,246 1,246 1,201 1,174 1,214 1,214 1,178 1,143 1,114 1,053 1,635 1,664 1,631 1,593 1,607 1,657 1,652 2,136
95 159 136 121 119 133 208 216 219 238 234 245 250 256 224 251 262 278 296 319 363 316 364 410 405 420 498 537 537 538 539 510 444 482 528 549 614 691 746 608
91 153 130 111 108 119 128 134 140 147 135 149 154 170 116 146 165 174 183 203 193 186 107 123 134 174 269 284 259 239 229 173 39 71 96 117 170 251 269 129
91 153 130 111 108 119 128 134 140 147 135 149 154 170 116 146 165 174 183 203 193 186 107 123 134 174 269 325 305 311 318 272 120 163 198 222 306 407 422 129
1.7 2.1 3.3 4.9 5.8 10.0 66 68 67 78 85 81 84 73 85 81 76 83 93 90 149 106 166 198 195 183 179 167 182 180 175 184 228 229 229 213 234 211 229 285
1.6 1.3 1.5 1.5 1.4 1.8 7.9 8.5 9.2 7.8 8.7 10.0 8.8 9.6 16 19 17 16 15 20 17 17 80 78 65 47 33 26 34 32 31 28 38 36 37 38 38 41 43 113
0.8 1.0 1.0 1.6 1.6 1.8 1.6 3.2 6.0 9.3 20 20 21 21 22 24 18 19 20 28 20 19 20 27 20 20 19 18 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – 132 130 130 134 134 134 134 134 134 134 146 162 151 148 146 146 146 190
2.3 2.1 2.0 1.9 1.9 0.0 486 454 421 44 41 37 33 30 386 369 353 336 319 302 286 269 826 777 610 567 530 493 456 422 387 353 947 891 836 780 725 670 614 1,186
24 27 25 29 26 31 605 591 576 200 208 216 220 219 494 491 471 458 476 461 491 489 1,050 1,048 1,004 979 1,035 1,013 999 948 892 837 1,401 1,435 1,397 1,360 1,333 1,355 1,340 1,824
22 23 25 29 26 31 250 265 280 187 189 196 201 202 244 252 242 239 230 227 269 280 374 415 414 434 413 435 465 458 446 462 459 510 487 465 453 440 435 590
-6.3 2.7 2.6 2.4 2.1 1.5 1.5 12 0.8 1.6 3.5 3.2 4.4 4.5 48 48 48 48 48 49 49 49 101 122 143 164 184 184 184 184 184 184 66 66 66 66 66 30 34 57
9.0 9.1 6.8 5.6 5.0 5.7 9.3 19 12 12 14 11 12 6.2 6.1 8.2 6.5 10 8.7 7.5 7.7 4.2 3.9 6.6 7.6 3.5 3.0 2.4 3.7 8.7 6.0 2.4 3.1 3.9 18 11 7.6 11 6.8 9.2
2.1 1.5 0.9 0.4 0.0 0.0 12 12 11 9.9 9.0 9.6 8.6 7.7 240 230 220 210 237 225 214 202 669 625 582 538 615 571 528 484 440 369 803 788 773 758 744 780 770 1,037
74 135 114 96 96 104 91 83 71 92 86 86 84 87 141 156 173 186 170 253 251 203 196 198 197 195 180 201 179 195 222 217 234 229 234 232 275 302 312 312
-196 -223 -246 -267 -281 -298 -317 -330 -346 -337 -347 -352 -358 -360 -359 -351 -340 -333 -312 -239 -231 -256 -269 -275 -274 -281 -299 -286 -265 -233 -205 -186 -177 -164 -162 -150 -118 -101 -87 -102
23 27 29 29 30 33 33 33 33 34 33 33 33 34 35 35 35 35 41 41 36 34 34 34 35 34 34 43 42 42 41 40 40 40 33 39 39 40 40 32

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?